Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Verenigd Koninkrijk
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. Nieuws
  7. Persberichten
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
uitgestelde koers. Vertraagde tijd London Stock Exchange - 24/09 17:39:22
1386.2 GBX   -2.09%
24/09Europese ADR's bewegen lager in de vrijdaghandel
MT
24/09GLAXOSMITHKLINE : UBS blijft neutraal
MD
23/09Uit onderzoek van GlaxoSmithKline blijkt dat meer mensen voorstander zijn van vaccinaties na COVID-19
MT
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť GLAXOSMITHKLINE PLC
24/09GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
24/09GLAXOSMITHKLINE : Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced I..
AQ
22/09GLAXOSMITHKLINE : Activist investor Bluebell takes stake in GSK to challenge chief exec
AQ
22/09GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
22/09GLAXOSMITHKLINE : Changing attitudes to vaccination after the COVID-19 pandemic could incr..
PU
22/09GLAXOSMITHKLINE : ViiV Healthcare to present key data that provides further support for th..
PU
20/09GLAXOSMITHKLINE : Director Declaration (Form 6-K)
PU
20/09GLAXOSMITHKLINE : GSK announces major renewable energy investment and low carbon inhaler p..
PU
17/09GLAXOSMITHKLINE : GSK receives CHMP positive opinions recommending approval of Nucala (mep..
PU
15/09CROSSWORD CYBERSECURITY PLC : Appointments URENCO CISO to Advisory Board
AQ
13/09GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
09/09GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
09/09GLAXOSMITHKLINE : GSK to highlight continued progress in oncology pipeline and portfolio w..
PU
06/09GLAXOSMITHKLINE : GSK Consumer Healthcare leads oral care industry with launch of its firs..
PU
03/09GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
31/08GLAXOSMITHKLINE : SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine..
PU
31/08GLAXOSMITHKLINE : SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine..
PU
25/08GLAXOSMITHKLINE : Safe Harbors Can Be Breached — Skinny Labeling, Drugs, And Patent ..
AQ
25/08GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
23/08GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
23/08GSK V. TEVA : Federal Circuit Issues New Opinion Analyzing Induced Infringement
AQ
16/08GLAXOSMITHKLINE : Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates ..
PU
11/08GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
29/07GLAXOSMITHKLINE : Q2 2021 results transcript PDF - 168.2KB
PU
28/07GLAXOSMITHKLINE : GSK delivers strong Q2 sales of £8.1 billion, +6% AER, +15% CER Total EP..
PU
28/07GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
28/07GLAXOSMITHKLINE : Q2 2021 US dollar translation PDF - 159.8KB
PU
28/07GLAXOSMITHKLINE : Q2 2021 results slides PDF - 803.4KB
PU
28/07GLAXOSMITHKLINE : Q2 2021 results infographic PDF - 517.3KB
PU
28/07GLAXOSMITHKLINE : Download full results announcement PDF - 1.2MB
PU
28/07GLAXOSMITHKLINE : GSK delivers strong Q2 sales of £8.1 billion, +6% AER, +15% CER Total EP..
PU
26/07GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
26/07GLAXOSMITHKLINE : Shingrix approved in the US for prevention of shingles in immunocompromi..
PU
23/07GLAXOSMITHKLINE : Board Committee Changes (Form 6-K)
PU
22/07GLAXOSMITHKLINE : Brian McNamara appointed CEO Designate of new independent Consumer Healt..
PU
22/07GLAXOSMITHKLINE : Brian McNamara appointed CEO Designate of new independent Consumer Healt..
PU
21/07GLAXOSMITHKLINE : Corporate Governance And Section 172 Statements For Applicable UK Subsid..
PU
19/07GLAXOSMITHKLINE : ViiV Healthcare study shows new long-acting HIV regimen Cabenuva (cabote..
AQ
19/07GLAXOSMITHKLINE : GSK announces positive headline results from five Phase 3 studies of dap..
AQ
17/07GLAXOSMITHKLINE : ViiV Healthcare study shows new long-acting HIV regimen Cabenuva (cabote..
PU
17/07GLAXOSMITHKLINE : ViiV Healthcare to present new data from diverse portfolio and pipeline ..
PU
16/07GLAXOSMITHKLINE : GSK announces positive headline results from five Phase 3 studies of dap..
PU
16/07GLAXOSMITHKLINE : GSK announces positive headline results from five Phase 3 studies of dap..
PU
16/07GLAXOSMITHKLINE : New study shows more needs to be done to raise public awareness on the i..
PU
16/07GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
16/07GLAXOSMITHKLINE : GSK unveils plan for one of Europe's largest life science campuses in St..
PU
14/07GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
05/07GLAXOSMITHKLINE : GSK and Alector announce global collaboration in immuno-neurology for tw..
AQ
02/07GLAXOSMITHKLINE : GSK and Alector announce global collaboration in immuno-neurology for tw..
PU
02/07GLAXOSMITHKLINE : GSK and Alector announce global collaboration in immuno-neurology for tw..
PU
02/07GLAXOSMITHKLINE : (the ‘Company' or 'GSK') (Form 6-K)
PU
29/06MALARIA PIPELINE : Emerging Therapies and Key pharma players involved by DelveInsight | Gl..
AQ
25/06GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
24/06Vaccines Market 2021 Precise Outlook- Pfizer Inc., GlaxoSmithKline plc, Merck & Co. etc..
AQ
23/06GLAXOSMITHKLINE : Download the presentation slides PDF - 7.8MB
PU
23/06ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHAN..
AQ
23/06GLAXOSMITHKLINE : New GSK to deliver step-change in growth and performance over next ten y..
PU
23/06GLAXOSMITHKLINE : New GSK to deliver step-change in growth and performance over next ten y..
PU
22/06ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHAN..
AQ
22/06GLAXOSMITHKLINE : ViiV Healthcare and Halozyme enter global collaboration and license agre..
PU
21/06GLAXOSMITHKLINE : GSK and Vir Biotechnology announce continuing progress of the COMET clin..
PU
18/06UNIVERSITY OF CAMBRIDGE : Apollo Therapeutics launches with GBP100m investment; Pioneering..
AQ
15/06GLAXOSMITHKLINE : signs $2bn cancer treatment deal with US biotech firm
AQ
14/06GLAXOSMITHKLINE : CECP presentation slides PDF - 505.4KB
PU
14/06GLAXOSMITHKLINE : Download the presentation slides PDF - 2.5MB
PU
14/06GLAXOSMITHKLINE : Material Event (Form 6-K)
PU
14/06GLAXOSMITHKLINE : GSK and iTeos Therapeutics announce development and commercialisation co..
PU
11/06GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
09/06GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
04/06GLAXOSMITHKLINE : GSK recommends shareholders reject mini-tender offer by TRC Capital (For..
PU
01/06GLAXOSMITHKLINE : GSK to showcase scientific advances and progress in oncology at ASCO and..
PU
31/05GLAXOSMITHKLINE : Eddie Gray appointed chair of Antivirals Taskforce
AQ
29/05GLAXOSMITHKLINE : NGO Donate N38m Covid-19 Palliatives to Lagos Hospitals
AQ
27/05GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
27/05GLAXOSMITHKLINE : Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-..
PU
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op GLAXOSMITHKLINE PLC
27/10/21
Komende gebeurtenissen in de sector